Literature DB >> 31313021

Oxidative stress and inflammatory profiles in obstructive sleep apnea: are short-term CPAP or aerobic exercise therapies effective?

Ytalo Gonçalves Borges1, Luis Henrique Ceia Cipriano1, Rafaela Aires1, Paulo Vinicios Camuzi Zovico2, Fabiana Vasconcelos Campos3, Maria Teresa Martins de Araújo4,5, Sonia Alves Gouvea1.   

Abstract

PURPOSE: The effects of medium to long-term continuous positive airway pressure (CPAP) or physical activity in decreasing oxidative stress, inflammatory, and cell-free DNA markers in obstructive sleep apnea (OSA) have been explored. Here we evaluate oxidative stress markers (TBARS, AOPP, SOD), proinflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8), anti-inflammatory cytokines (IL-4, IL-10), and cell-free DNA levels before and after 8-week CPAP treatment or moderate-intensity aerobic training in moderate to severe OSA.
METHODS: Thirty-nine patients diagnosed with OSA were randomly divided into CPAP (N = 18), with or without humidifier, and exercise groups (N = 21). Excessive daytime sleepiness and sleep quality were assessed by the Epworth Sleepiness Scale and the Pittsburgh questionnaire, respectively. Biomarkers for lipid and protein oxidation, pro and anti-inflammatory cytokines, and cell-free DNA were quantified in blood samples, before and after 8 weeks of both treatments.
RESULTS: After 8 weeks of either CPAP or exercise, no significant differences were observed in the levels of cell-free DNA, oxidative stress, and inflammation markers, except for an increase in AOPP and IL-17A levels in individuals who went through CPAP, which were higher when the CPAP device was used without the humidifier. We have also observed that CPAP significantly decreased the Pittsburgh scores and improved sleep efficiency and hours of sleep, while ESS scores remained unaffected.
CONCLUSIONS: Short-term treatment for OSA, be it CPAP therapy or moderate-intensity aerobic exercise, was not sufficient to alter either the oxidative stress and inflammatory profiles or the cell-free DNA levels of moderate to severe OSA patients. Short-term CPAP did, however, improve self-reported sleep quality.

Entities:  

Keywords:  Aerobic exercise; CPAP therapy; Inflammation; Obstructive sleep apnea; Oxidative stress

Mesh:

Substances:

Year:  2019        PMID: 31313021     DOI: 10.1007/s11325-019-01898-0

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  6 in total

Review 1.  Association between the circulating superoxide dismutase and obstructive sleep apnea: a meta-analysis.

Authors:  Zongsheng Tian; Hongying Sun; Jing Kang; Zhuangzhuang Mu; Jianmin Liang; Mingxian Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-09-02       Impact factor: 2.503

2.  Concurrent alteration in inflammatory biomarker gene expression and oxidative stress: how aerobic training and vitamin D improve T2DM.

Authors:  Rastegar Hoseini; Hiwa Ahmed Rahim; Jalal Khdhr Ahmed
Journal:  BMC Complement Med Ther       Date:  2022-06-22

Review 3.  Cardiovascular Disorders Triggered by Obstructive Sleep Apnea-A Focus on Endothelium and Blood Components.

Authors:  Jakub Mochol; Jakub Gawrys; Damian Gajecki; Ewa Szahidewicz-Krupska; Helena Martynowicz; Adrian Doroszko
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

Review 4.  The Assessment of Endothelial Dysfunction among OSA Patients after CPAP Treatment.

Authors:  Klaudia Brożyna-Tkaczyk; Wojciech Myśliński; Jerzy Mosiewicz
Journal:  Medicina (Kaunas)       Date:  2021-03-25       Impact factor: 2.430

5.  Atorvastatin attenuates intermittent hypoxia-induced myocardial oxidative stress in a mouse obstructive sleep apnea model.

Authors:  Xiao-Bin Zhang; Hui-Juan Cheng; Ya-Ting Yuan; Yan Chen; Yi-Yuan Chen; Kam Yu Chiu; Hui-Qing Zeng
Journal:  Aging (Albany NY)       Date:  2021-07-21       Impact factor: 5.682

Review 6.  Oxidative Stress Markers among Obstructive Sleep Apnea Patients.

Authors:  Agata Stanek; Klaudia Brożyna-Tkaczyk; Wojciech Myśliński
Journal:  Oxid Med Cell Longev       Date:  2021-07-19       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.